Novavax Inc. (NVAX) 2.35 -0.15

Trade NVAX
NOW!
Last Trade:2.33Short Ratio:9.90
Last Trade Time:5:00pmDay Range:2.32 - 2.53
Ask:2.35Year Range:0.52 - 7.79
Bid:2.29One Year Target:7.92
Open:2.51Exchange:NGM
Volume:1883672EBITDA:-30.4M
Prev. Close:2.48Market Cap:217.8M
50 Day Moving:2.31Div Yield:
200 day moving:3.4594PE:

Related RealMoney articles from TheStreet.com

Retail Sales: Tomorrow's Headliners

Novavax: The Trend Continues Down (NVAX)

Posted on 03/12/10 at 12:33pm
SmarTrend identified a Downtrend for Novavax (NASDAQ: NVAX) on September 17, 2009 at $5.00. In approximately 6 months, Novavax has returned 52.2% as of today's recent price of $2.39.
Click here to read the rest of the article

Novavax Posts Wider-Than-Expected Loss; Investors Flee (NVAX)

Posted on 03/12/10 at 9:48am
3/12/2010-Shares of Novavax (NASDAQ: NVAX) are trading 4.4% lower to $2.37 premarket Friday after the company reported a Q4 loss of $0.15 per share, missing consensus estimates for a loss of $0.06 per share.
Click here to read the rest of the article

NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference

Posted on 03/11/10 at 4:30pm
NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference PR Newswire ROCKVILLE, Md., March 11
Click here to read the rest of the article

Cleantech Goes Mainstream at ROTH Capital Partners 22nd Annual OC Growth Stock Conference March 15-17, 2010

Posted on 03/11/10 at 2:42pm
NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing finan
Click here to read the rest of the article

Biotech Stocks in Focus are BPAX, CYCC, INSM, SNSS, INCY, NVAX

Posted on 03/11/10 at 4:00am
(EMAILWIRE.COM, March 11, 2010 ) Dallas, Tx - Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) climbed 6.82% over its previous day's price and now trades at $2.82. The stock has a 52-week range of $0.27-$4.08. So far in this year the stock went up over 171%.
Click here to read the rest of the article

Media & Internet Companies Get Spotlight at ROTH Capital Partners 22nd Annual OC Growth Stock Conference March 15-17, 2010

Posted on 03/08/10 at 1:15pm
NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing finan
Click here to read the rest of the article

NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico

Posted on 03/08/10 at 9:15am
NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico - Enrollment in largest clinical study in Novavax's history of over 4,500 subjects completed in less than 5 months PR Newswire
Click here to read the rest of the article

NOVAVAX to Present at Cowen and Company's 30th Annual Health Care Conference

Posted on 03/05/10 at 9:06am
NOVAVAX to Present at Cowen and Company's 30th Annual Health Care Conference PR Newswire ROCKVILLE, Md., March 5
Click here to read the rest of the article

NOVAVAX Announces Release Date of 2009 Year-End Financial Results and Investor Conference Call

Posted on 03/04/10 at 9:15am
NOVAVAX Announces Release Date of 2009 Year-End Financial Results and Investor Conference Call PR Newswire ROCKVILLE, Md., March 4
Click here to read the rest of the article

Novavax Downward Momentum Looks to Continue (NVAX)

Posted on 03/04/10 at 6:12am
SmarTrend identified a Downtrend for Novavax (NASDAQ: NVAX) on September 17, 2009 at $5.00. In approximately 6 months, Novavax has returned 53.4% as of today's recent price of $2.33.
Click here to read the rest of the article